Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

G. J. van Baaren* (Corresponding Author), M. M.C. Bruijn, B. W. Mol

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing'. Together they form a unique fingerprint.

Medicine & Life Sciences